Nasdaq says RenovoRx (NASDAQ: RNXT) back in line after sub-$1 share slump
Rhea-AI Filing Summary
RenovoRx, Inc. (RNXT) reports that its common stock has regained compliance with Nasdaq’s Minimum Bid Price Requirement under Listing Rule 5550(a)(2). The company previously received notice of non-compliance on December 31, 2025, after its closing bid price remained below $1.00 per share for 30 consecutive business days.
Nasdaq informed RenovoRx on August 20, 2026 that, for the ten consecutive business days from August 6, 2026 through August 19, 2026, the closing bid price of its common stock was $1.00 per share or greater. As a result, RenovoRx is now back in compliance with the Nasdaq minimum bid price standard and Nasdaq considers the matter closed.
Positive
- RenovoRx has regained compliance with Nasdaq’s Minimum Bid Price Requirement, removing the immediate delisting risk related to its stock price.
- The stock met the minimum bid price of $1.00 per share or higher for 10 consecutive business days, confirming sustained compliance rather than a single-day spike.
Negative
- None.
8-K Event Classification
Item 8.01 — Other Events
1 item
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Key Figures
Minimum bid price threshold: $1.00 per share
Compliance measurement period: 10 consecutive business days
Non-compliance notice date: December 31, 2025
+1 more
4 metrics
Minimum bid price threshold
$1.00 per share
Nasdaq Listing Rule 5550(a)(2) Minimum Bid Price Requirement
Compliance measurement period
10 consecutive business days
From August 6, 2026 through August 19, 2026 with closing bid at or above $1.00
Non-compliance notice date
December 31, 2025
Date Nasdaq notified RenovoRx of failure to meet the Minimum Bid Price Requirement
Compliance confirmation date
August 20, 2026
Date Nasdaq informed RenovoRx that it had regained compliance and closed the matter
Key Terms
Minimum Bid Price Requirement, Nasdaq Listing Rule 5550(a)(2), closing bid price
3 terms
Minimum Bid Price Requirement market
"RenovoRx Regains Compliance with Nasdaq Minimum Bid Price Requirement"
A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.
Nasdaq Listing Rule 5550(a)(2) regulatory
"not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”)"
closing bid price market
"the closing bid price of the Common Stock had been $1.00 per share or greater"
The closing bid price is the last price that a buyer was willing to pay for a security at the end of the trading day. It reflects the final visible demand for the stock — like the last offer someone makes for a used car before a yard closes — and helps investors gauge market interest, set valuations, and mark portfolios to market for that day.
FAQ
What did RenovoRx (RNXT) announce regarding its Nasdaq listing status?
RenovoRx announced that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), the Minimum Bid Price Requirement. Nasdaq notified the company that the matter is now considered closed after the stock traded at or above $1.00 per share for 10 consecutive business days.
Why was RenovoRx (RNXT) previously non-compliant with Nasdaq rules?
On December 31, 2025, RenovoRx received notice from Nasdaq that it was not in compliance with Listing Rule 5550(a)(2) because its closing bid price had been below $1.00 per share for the preceding 30 consecutive business days.
How did RenovoRx (RNXT) regain compliance with the Nasdaq minimum bid price rule?
Nasdaq confirmed that from August 6, 2026 through August 19, 2026, RenovoRx’s closing bid price was $1.00 per share or greater for 10 consecutive business days, satisfying the Minimum Bid Price Requirement and restoring compliance.
Does Nasdaq still have an open compliance issue with RenovoRx (RNXT)?
No. Nasdaq informed RenovoRx on August 20, 2026 that the company has regained compliance with the Minimum Bid Price Requirement and that Nasdaq now considers the matter closed.
What Nasdaq rule applies to RenovoRx’s minimum bid price requirement?
RenovoRx’s stock is subject to Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share. The company regained compliance after maintaining a closing bid at or above this level for 10 consecutive business days.
AI-generated analysis. How Rhea-AI works. Not financial advice.
